Mutual Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $630K | Buy |
16,605
+2,762
| +20% | +$105K | 0.02% | 677 |
|
|
2025
Q1 | $518K | Buy |
13,843
+5
| +0% | +$187 | 0.01% | 692 |
|
|
2024
Q4 | $463K | Sell |
13,838
-423
| -3% | -$14.1K | 0.01% | 726 |
|
|
2024
Q3 | $538K | Sell |
14,261
-4,887
| -26% | -$184K | 0.02% | 676 |
|
|
2024
Q2 | $766K | Buy |
19,148
+6,869
| +56% | +$275K | 0.02% | 569 |
|
|
2024
Q1 | $526K | Buy |
12,279
+2,175
| +22% | +$93.2K | 0.02% | 678 |
|
|
2023
Q4 | $374K | Buy |
10,104
+452
| +5% | +$16.8K | 0.01% | 746 |
|
|
2023
Q3 | $350K | Sell |
9,652
-443
| -4% | -$16.1K | 0.01% | 725 |
|
|
2023
Q2 | $360K | Sell |
10,095
-12,569
| -55% | -$448K | 0.01% | 741 |
|
|
2023
Q1 | $806K | Sell |
22,664
-3,141
| -12% | -$112K | 0.03% | 488 |
|
|
2022
Q4 | $907K | Buy |
25,805
+727
| +3% | +$25.5K | 0.04% | 432 |
|
|
2022
Q3 | $738K | Sell |
25,078
-1,180
| -4% | -$34.7K | 0.04% | 452 |
|
|
2022
Q2 | $1.43M | Buy |
26,258
+6,775
| +35% | +$369K | 0.09% | 252 |
|
|
2022
Q1 | $1.06M | Buy |
19,483
+2,961
| +18% | +$161K | 0.06% | 357 |
|
|
2021
Q4 | $911K | Buy |
16,522
+5,825
| +54% | +$321K | 0.05% | 411 |
|
|
2021
Q3 | $511K | Buy |
10,697
+2,978
| +39% | +$142K | 0.03% | 533 |
|
|
2021
Q2 | $384K | Buy |
7,719
+2,761
| +56% | +$137K | 0.02% | 613 |
|
|
2021
Q1 | $221K | Sell |
4,958
-476
| -9% | -$21.2K | 0.02% | 703 |
|
|
2020
Q4 | $250K | Sell |
5,434
-31
| -0.6% | -$1.43K | 0.02% | 643 |
|
|
2020
Q3 | $257K | Buy |
5,465
+407
| +8% | +$19.1K | 0.02% | 574 |
|
|
2020
Q2 | $258K | Buy |
5,058
+455
| +10% | +$23.2K | 0.03% | 537 |
|
|
2020
Q1 | $218K | Sell |
4,603
-409
| -8% | -$19.4K | 0.03% | 475 |
|
|
2019
Q4 | $294K | Buy |
5,012
+653
| +15% | +$38.3K | 0.03% | 466 |
|
|
2019
Q3 | $233K | Buy |
+4,359
| New | +$233K | 0.03% | 470 |
|
|
2018
Q2 | – | Sell |
-5,657
| Closed | -$276K | – | 426 |
|
|
2018
Q1 | $276K | Buy |
+5,657
| New | +$276K | 0.07% | 323 |
|